Lista de obras -

18-Fluorodeoxyglucose positron emission tomography for tuberculosis diagnosis and management: a case series

artículo científico publicado en 2013

Application of quantitative second-line drug susceptibility testing at a multidrug-resistant tuberculosis hospital in Tanzania

artículo científico publicado en 2013

Comparison of overnight pooled and standard sputum collection method for patients with suspected pulmonary tuberculosis in northern Tanzania

artículo científico publicado en 2012

Correction: Prevalence and extent of heteroresistance by next generation sequencing of multidrug-resistant tuberculosis

artículo científico publicado en 2017

Diagnosis and interim treatment outcomes from the first cohort of multidrug-resistant tuberculosis patients in Tanzania

artículo científico publicado en 2013

Discordance across several methods for drug susceptibility testing of drug-resistant Mycobacterium tuberculosis isolates in a single laboratory

artículo científico publicado en 2013

Early Therapeutic Drug Monitoring for Isoniazid and Rifampin among Diabetics with Newly Diagnosed Tuberculosis in Virginia, USA.

artículo científico publicado en 2013

Early interventions for diabetes related tuberculosis associate with hastened sputum microbiological clearance in Virginia, USA.

artículo científico publicado en 2017

Evaluation of cytokines in peripheral blood mononuclear cell supernatants for the diagnosis of tuberculosis

scholarly article by Margaretha Sariko et al published 2019 in Journal of Inflammation Research

Evaluation of the Antibody in Lymphocyte Supernatant Assay to Detect Active Tuberculosis

artículo científico publicado en 2017

Hearing loss with Kanamycin treatment for multidrug-resistant tuberculosis in Bangladesh

artículo científico publicado en 2018

Improvement in plasma drug activity during the early treatment interval among Tanzanian patients with multidrug-resistant tuberculosis

artículo científico publicado en 2015

Integrated microfluidic card with TaqMan probes and high-resolution melt analysis to detect tuberculosis drug resistance mutations across 10 genes

artículo científico publicado en 2015

Mycobacterial infections in a large Virginia hospital, 2001-2009 ⬇️

artículo científico publicado el 5 de mayo de 2011

Optimizing Second-Line Therapy for Drug-Resistant Tuberculosis: the Additive Value of Sequencing for Multiple Resistance Loci ⬇️

artículo científico publicado el 1 de agosto de 2011

Outcomes and use of therapeutic drug monitoring in multidrug-resistant tuberculosis patients treated in virginia, 2009-2014

artículo científico publicado en 2015

Pharmacokinetics of First-Line Drugs Among Children With Tuberculosis in Rural Tanzania

artículo científico publicado en 2020

Pharmacokinetics of tuberculosis drugs in HIV infected patients from Irkutsk, Russian Federation: redefining drug activity

artículo científico publicado en 2018

Plasma drug activity assay for treatment optimization in tuberculosis patients

artículo científico publicado en 2011

Plasma drug activity in patients on treatment for multidrug-resistant tuberculosis

artículo científico publicado en 2013

Prevalence and extent of heteroresistance by next generation sequencing of multidrug-resistant tuberculosis

artículo científico publicado en 2017

Primary multidrug-resistant Mycobacterium tuberculosis in 2 regions, Eastern Siberia, Russian Federation

artículo científico publicado en 2013

Quantitative drug-susceptibility in patients treated for multidrug-resistant tuberculosis in Bangladesh: implications for regimen choice

artículo científico publicado en 2015

Rapid first- and second-line drug susceptibility assay for Mycobacterium tuberculosis isolates by use of quantitative PCR.

artículo científico publicado en 2010

Sensititre MycoTB plate compared to Bactec MGIT 960 for first- and second-line antituberculosis drug susceptibility testing in Tanzania: a call to operationalize MICs

artículo científico publicado en 2015

The future of molecular diagnostics for drug-resistant tuberculosis ⬇️

artículo científico publicado el 1 de mayo de 2012

Therapeutic Drug Monitoring for Slow Response to Tuberculosis Treatment in a State Control Program, Virginia, USA ⬇️

artículo científico publicado el 1 de octubre de 2010

eis Promoter C14G and C15G Mutations Do Not Confer Kanamycin Resistance in Mycobacterium tuberculosis

artículo científico publicado en 2016

Lista de obras de

18-Fluorodeoxyglucose positron emission tomography for tuberculosis diagnosis and management: a case series

Application of quantitative second-line drug susceptibility testing at a multidrug-resistant tuberculosis hospital in Tanzania

Comparison of overnight pooled and standard sputum collection method for patients with suspected pulmonary tuberculosis in northern Tanzania

Correction: Prevalence and extent of heteroresistance by next generation sequencing of multidrug-resistant tuberculosis

Diagnosis and interim treatment outcomes from the first cohort of multidrug-resistant tuberculosis patients in Tanzania

Discordance across several methods for drug susceptibility testing of drug-resistant Mycobacterium tuberculosis isolates in a single laboratory

Early Therapeutic Drug Monitoring for Isoniazid and Rifampin among Diabetics with Newly Diagnosed Tuberculosis in Virginia, USA.

Early interventions for diabetes related tuberculosis associate with hastened sputum microbiological clearance in Virginia, USA.

Evaluation of cytokines in peripheral blood mononuclear cell supernatants for the diagnosis of tuberculosis

Evaluation of the Antibody in Lymphocyte Supernatant Assay to Detect Active Tuberculosis

Hearing loss with Kanamycin treatment for multidrug-resistant tuberculosis in Bangladesh

Improvement in plasma drug activity during the early treatment interval among Tanzanian patients with multidrug-resistant tuberculosis

Integrated microfluidic card with TaqMan probes and high-resolution melt analysis to detect tuberculosis drug resistance mutations across 10 genes

Mycobacterial infections in a large Virginia hospital, 2001-2009 ⬇️

Optimizing Second-Line Therapy for Drug-Resistant Tuberculosis: the Additive Value of Sequencing for Multiple Resistance Loci ⬇️

Outcomes and use of therapeutic drug monitoring in multidrug-resistant tuberculosis patients treated in virginia, 2009-2014

Pharmacokinetics of First-Line Drugs Among Children With Tuberculosis in Rural Tanzania

Pharmacokinetics of tuberculosis drugs in HIV infected patients from Irkutsk, Russian Federation: redefining drug activity

Plasma drug activity assay for treatment optimization in tuberculosis patients

Plasma drug activity in patients on treatment for multidrug-resistant tuberculosis

Prevalence and extent of heteroresistance by next generation sequencing of multidrug-resistant tuberculosis

Primary multidrug-resistant Mycobacterium tuberculosis in 2 regions, Eastern Siberia, Russian Federation

Quantitative drug-susceptibility in patients treated for multidrug-resistant tuberculosis in Bangladesh: implications for regimen choice

Rapid first- and second-line drug susceptibility assay for Mycobacterium tuberculosis isolates by use of quantitative PCR.

Sensititre MycoTB plate compared to Bactec MGIT 960 for first- and second-line antituberculosis drug susceptibility testing in Tanzania: a call to operationalize MICs

The future of molecular diagnostics for drug-resistant tuberculosis ⬇️

Therapeutic Drug Monitoring for Slow Response to Tuberculosis Treatment in a State Control Program, Virginia, USA ⬇️

eis Promoter C14G and C15G Mutations Do Not Confer Kanamycin Resistance in Mycobacterium tuberculosis